Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Live Attenuated Intranasal Influenza Vaccine Exposure on Mucosal Immunity

NCT07093281 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT07093281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07093281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Live Attenuated Intranasal Influenza Vaccine Exposure on Mucosal Immunity
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 28, 2027
Completion date
July 31, 2029
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impact of vaccination